NASDAQ:PMD Psychemedics (PMD) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PMD Stock Alerts $2.62 +0.08 (+3.15%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$2.55▼$2.6650-Day Range$2.54▼$3.1852-Week Range$2.06▼$5.59Volume655 shsAverage Volume11,078 shsMarket Capitalization$15.22 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Psychemedics alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Psychemedics Stock (NASDAQ:PMD)Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, Fentanyl, and alcohol. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Dallas, Texas.Read More PMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PMD Stock News HeadlinesApril 25, 2024 | finance.yahoo.comPsychemedics Corporation (PMD) Stock Price, News, Quote & History - Yahoo FinanceMarch 28, 2024 | investorplace.comPMD Stock Earnings: Psychemedics Reported Results for Q4 2023April 26, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 28, 2024 | globenewswire.comPsychemedics Corporation Reports 2023 Financial ResultsMarch 21, 2024 | globenewswire.comPsychemedics Recognized as a Top 10 Employee Health Testing Services ProviderJanuary 3, 2024 | bizjournals.comSmall cap drug testing company relocates HQ to DFW from MassachusettsJanuary 2, 2024 | msn.comMassachusetts drug testing firm targeting fentanyl relocates corporate HQ to DallasJanuary 2, 2024 | markets.businessinsider.comPsychemedics Corporation Announces Relocation of Headquarters to Dallas, TexasApril 26, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.November 10, 2023 | msn.comPsychemedics reports Q3 resultsNovember 9, 2023 | finance.yahoo.comPsychemedics Corporation Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | morningstar.comPsychemedics Corp PMDOctober 27, 2023 | finance.yahoo.comUnveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug ScreenSeptember 26, 2023 | benzinga.comPsychemedics Chief Revenue Officer Awarded $448K Worth of Stock OptionsSeptember 22, 2023 | benzinga.comPsychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue OfficerSeptember 21, 2023 | msn.comDo You Get PMS? You Could Be Headed for Early Menopause, Study ShowsAugust 22, 2023 | benzinga.comPresident & CEO at Psychemedics Acquires Company Stock Options Worth 300,000 SharesAugust 18, 2023 | finance.yahoo.comPsychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 11, 2023 | marketwatch.comPsychemedics 2Q Loss Widens Amid Labor Shortage, SettlementAugust 11, 2023 | marketwatch.comPsychemedics Eliminates DividendAugust 11, 2023 | finance.yahoo.comPsychemedics Corporation Reports Second Quarter 2023 Financial ResultsJuly 12, 2023 | marketwatch.comPsychemedics Taps Brian Hullinger as Successor of Long-Time CEO Ray KubackiJuly 12, 2023 | finance.yahoo.comPsychemedics Corporation Announces CEO Succession PlanMay 19, 2023 | msn.comPsychemedics's Ex-Dividend Date Is Wednesday, Here's What You Need To KnowMay 19, 2023 | finance.yahoo.comDo These 3 Checks Before Buying Psychemedics Corporation (NASDAQ:PMD) For Its Upcoming DividendMay 13, 2023 | finance.yahoo.comPsychemedics (NASDAQ:PMD) Is Paying Out A Dividend Of $0.07May 12, 2023 | msn.comPsychemedics (PMD) Declares $0.07 DividendSee More Headlines Receive PMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/26/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:PMD CUSIPN/A CIK806517 Webwww.psychemedics.com Phone(978) 206-8220Fax978-264-9236Employees116Year Founded1985Profitability EPS (Most Recent Fiscal Year)($0.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,150,000.00 Net Margins-18.39% Pretax Margin-15.56% Return on Equity-48.68% Return on Assets-26.77% Debt Debt-to-Equity RatioN/A Current Ratio1.45 Quick Ratio1.45 Sales & Book Value Annual Sales$22.10 million Price / Sales0.67 Cash FlowN/A Price / Cash FlowN/A Book Value$1.15 per share Price / Book2.22Miscellaneous Outstanding Shares5,810,000Free Float4,413,000Market Cap$14.82 million OptionableNot Optionable Beta0.64 Social Links Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Brian Hullinger (Age 56)President, CEO & Director Comp: $361.37kMs. Daniella Mehalik (Age 34)Vice President of Finance Comp: $126.41kMs. Shannon ShoemakerChief Revenue OfficerDr. Werner A. Baumgartner Ph.D.FounderMs. Annette BaumgartnerFounderMr. Michael Weisenhoff (Age 34)Principal Financial & Accounting Manager Mr. Patrick J. Kinney Jr.SecretaryMore ExecutivesKey CompetitorsCentogeneNASDAQ:CNTGBioNexus Gene LabNASDAQ:BGLCDermTechNASDAQ:DMTKOpGenNASDAQ:OPGNExagenNASDAQ:XGNView All CompetitorsInsidersCharles M DoucotSold 12,700 sharesTotal: $59,182.00 ($4.66/share)View All Insider Transactions PMD Stock Analysis - Frequently Asked Questions How have PMD shares performed in 2024? Psychemedics' stock was trading at $2.96 at the beginning of the year. Since then, PMD shares have decreased by 11.5% and is now trading at $2.62. View the best growth stocks for 2024 here. When is Psychemedics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our PMD earnings forecast. How were Psychemedics' earnings last quarter? Psychemedics Co. (NASDAQ:PMD) released its quarterly earnings results on Thursday, March, 28th. The company reported ($0.16) earnings per share for the quarter. The firm had revenue of $5 million for the quarter. Psychemedics had a negative trailing twelve-month return on equity of 48.68% and a negative net margin of 18.39%. How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics? Psychemedics announced a quarterly dividend on Tuesday, May 9th. Shareholders of record on Thursday, May 25th will be given a dividend of $0.07 per share on Thursday, June 8th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 10.69%. The ex-dividend date is Wednesday, May 24th. Read our dividend analysis for PMD. What is Raymond C. Kubacki Jr.'s approval rating as Psychemedics' CEO? 6 employees have rated Psychemedics Chief Executive Officer Raymond C. Kubacki Jr. on Glassdoor.com. Raymond C. Kubacki Jr. has an approval rating of 67% among the company's employees. What other stocks do shareholders of Psychemedics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Psychemedics investors own include Zynerba Pharmaceuticals (ZYNE), Dominion Energy (D), Sorrento Therapeutics (SRNE), AT&T (T), AbbVie (ABBV), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pattern Energy Group (PEGI) and Simon Property Group (SPG). How do I buy shares of Psychemedics? Shares of PMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PMD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psychemedics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
